Combined Assessment of EZH2 and EGFR as Potential Diagnostic Biomarkers for Epithelial Ovarian Tumors: Bioinformatics Analysis and Clinical Validation.

Wang X, Ma Y, Lu H

Open source

DOI
10.2147/ijwh.s633044
Published
2026
Container
International journal of women's health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijwh.s633044,
  title = {Combined Assessment of EZH2 and EGFR as Potential Diagnostic Biomarkers for Epithelial Ovarian Tumors: Bioinformatics Analysis and Clinical Validation.},
  author = {Wang X and Ma Y and Lu H},
  year = {2026},
  journal = {International journal of women's health},
  doi = {10.2147/ijwh.s633044},
  url = {https://doi.org/10.2147/ijwh.s633044}
}

RIS

TY  - JOUR
TI  - Combined Assessment of EZH2 and EGFR as Potential Diagnostic Biomarkers for Epithelial Ovarian Tumors: Bioinformatics Analysis and Clinical Validation.
AU  - Wang X
AU  - Ma Y
AU  - Lu H
PY  - 2026
JO  - International journal of women's health
DO  - 10.2147/ijwh.s633044
UR  - https://doi.org/10.2147/ijwh.s633044
ER  - 

APA

X, W., Y, M., & H, L. (2026). Combined Assessment of EZH2 and EGFR as Potential Diagnostic Biomarkers for Epithelial Ovarian Tumors: Bioinformatics Analysis and Clinical Validation.. International journal of women's health. https://doi.org/10.2147/ijwh.s633044

Source records